VivoSeq
Other

Olfactory Dysfunction

0

Pipeline Programs↗

4

Active Trials↗

0

Companies Involved↗

Olfactory Dysfunction is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Not yet recruiting4 · 80%
Unknown status1 · 20%

Clinical Trials

Trial Activity

Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation
Not yet recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 2·NCT04918953·90 enrolled
The Effect of Modified Olfactory Training on Postoperative Olfactory Dysfunction in Patients With CRS
Not yet recruiting·PPeking University Third Hospital·N/A·NCT06837051·213 enrolled
The Effect of Platelet-rich Plasma Nasal Injection in the Treatment of Traumatic Olfactory Dysfunction
Not yet recruiting·TTaichung Veterans General Hospital·Phase 3·NCT06290219·80 enrolled
The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction
Unknown status·EEye & ENT Hospital of Fudan University·N/A·NCT05448898·278 enrolled
Olfactory Dysfunction in Aging Adults
Not yet recruiting·MMedical University of South Carolina·N/A·NCT07660887·500 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)